122 related articles for article (PubMed ID: 32104327)
1. Molecularly imprinted nanoparticles and their releasing properties, bio-distribution as drug carriers.
Zhu Y; Yang L; Huang D; Zhu Q
Asian J Pharm Sci; 2017 Mar; 12(2):172-178. PubMed ID: 32104327
[TBL] [Abstract][Full Text] [Related]
2. Vinblastine-Loaded Nanoparticles with Enhanced Tumor-Targeting Efficiency and Decreasing Toxicity: Developed by One-Step Molecular Imprinting Process.
Zhu Y; Liu R; Huang H; Zhu Q
Mol Pharm; 2019 Jun; 16(6):2675-2689. PubMed ID: 31050894
[TBL] [Abstract][Full Text] [Related]
3. Development of Molecularly Imprinted Olanzapine Nano-particles: In Vitro Characterization and In Vivo Evaluation.
Jafary Omid N; Morovati H; Amini M; Dehpour AR; Partoazar A; Rafiee-Tehrani M; Dorkoosh F
AAPS PharmSciTech; 2016 Dec; 17(6):1457-1467. PubMed ID: 26831447
[TBL] [Abstract][Full Text] [Related]
4. Altered pharmacokinetics of vinblastine in Mdr1a P-glycoprotein-deficient Mice.
van Asperen J; Schinkel AH; Beijnen JH; Nooijen WJ; Borst P; van Tellingen O
J Natl Cancer Inst; 1996 Jul; 88(14):994-9. PubMed ID: 8667431
[TBL] [Abstract][Full Text] [Related]
5. Tuning surface-cross-linking of molecularly imprinted cross-linked micelles for molecular recognition in water.
Zhang S; Zhao Y
J Mol Recognit; 2019 Apr; 32(4):e2769. PubMed ID: 30419606
[TBL] [Abstract][Full Text] [Related]
6. Analysis of drug transport kinetics in multidrug-resistant cells using a novel coumarin-vinblastine compound.
Bornmann WG; Roepe PD
Biochemistry; 1994 Oct; 33(42):12665-75. PubMed ID: 7918493
[TBL] [Abstract][Full Text] [Related]
7. Microfluidic Synthesis of Vinblastine-Loaded Multifunctional Particles for Magnetically Responsive Controlled Drug Release.
Huang KS; Yang CH; Wang YC; Wang WT; Lu YY
Pharmaceutics; 2019 May; 11(5):. PubMed ID: 31058849
[TBL] [Abstract][Full Text] [Related]
8. Multidrug resistance-reversing agents increase vinblastine distribution in normal tissues expressing the P-glycoprotein but do not enhance drug penetration in brain and testis.
Arboix M; Paz OG; Colombo T; D'Incalci M
J Pharmacol Exp Ther; 1997 Jun; 281(3):1226-30. PubMed ID: 9190857
[TBL] [Abstract][Full Text] [Related]
9. Construction of molecularly imprinted nanoparticles by employing ultrasound waves for selective determination of doxepin from human plasma samples: Modeling and optimization.
Bahrani S; Ghaedi M; Arabi M
Biomed Chromatogr; 2019 Dec; 33(12):e4675. PubMed ID: 31378955
[TBL] [Abstract][Full Text] [Related]
10. Paclitaxel molecularly imprinted polymer-PEG-folate nanoparticles for targeting anticancer delivery: Characterization and cellular cytotoxicity.
Esfandyari-Manesh M; Darvishi B; Ishkuh FA; Shahmoradi E; Mohammadi A; Javanbakht M; Dinarvand R; Atyabi F
Mater Sci Eng C Mater Biol Appl; 2016 May; 62():626-33. PubMed ID: 26952466
[TBL] [Abstract][Full Text] [Related]
11. Combinations of paclitaxel and vinblastine and their effects on tubulin polymerization and cellular cytotoxicity: characterization of a synergistic schedule.
Giannakakou P; Villalba L; Li H; Poruchynsky M; Fojo T
Int J Cancer; 1998 Jan; 75(1):57-63. PubMed ID: 9426691
[TBL] [Abstract][Full Text] [Related]
12. Kinetic study on the mechanism of tissue distribution of vinblastine.
Wierzba K; Sugiyama Y; Iga T; Hanano M
J Pharmacobiodyn; 1988 Oct; 11(10):651-61. PubMed ID: 3221299
[TBL] [Abstract][Full Text] [Related]
13. [Study on chitosan-modified tripterygium glycoside nanoparticles and its renal targeting property].
Chen XK; Wei YH; Yao JN; Zhao YM; Shang XG; Li FZ
Zhongguo Zhong Yao Za Zhi; 2013 Feb; 38(4):548-52. PubMed ID: 23713281
[TBL] [Abstract][Full Text] [Related]
14. Magnetic iron-based nanoparticles biogeochemical behavior in soil-plant system: A critical review.
Zheng T; Zhou Q; Tao Z; Ouyang S
Sci Total Environ; 2023 Dec; 904():166643. PubMed ID: 37647959
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and evaluation of uniformly sized nalidixic acid-imprinted nanospheres based on precipitation polymerization method for analytical and biomedical applications.
Abouzarzadeh A; Forouzani M; Jahanshahi M; Bahramifar N
J Mol Recognit; 2012 Jul; 25(7):404-13. PubMed ID: 22733549
[TBL] [Abstract][Full Text] [Related]
16. Increase of sensitivity and uptake of vinblastine by reserpine in rat ascites hepatoma.
Wakusawa S; Miyamoto K; Koshiura R
Jpn J Pharmacol; 1984 Oct; 36(2):187-95. PubMed ID: 6513200
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of Biotin-Modified Galactosylated Chitosan Nanoparticles and Their Characteristics in Vitro and in Vivo.
Cheng M; Ma D; Zhi K; Liu B; Zhu W
Cell Physiol Biochem; 2018; 50(2):569-584. PubMed ID: 30308481
[TBL] [Abstract][Full Text] [Related]
18. Cytogenetic consequences of vinblastine treatment in mouse bone marrow.
Choudhury RC; Palo AK; Padhy A
Chemotherapy; 2004 Oct; 50(4):171-7. PubMed ID: 15347909
[TBL] [Abstract][Full Text] [Related]
19. Tissue disposition, excretion and metabolism of vinblastine in mice as determined by high-performance liquid chromatography.
van Tellingen O; Beijnen JH; Nooijen WJ; Bult A
Cancer Chemother Pharmacol; 1993; 32(4):286-92. PubMed ID: 8324870
[TBL] [Abstract][Full Text] [Related]
20. Water-soluble molecularly imprinted nanoparticles (MINPs) with tailored, functionalized, modifiable binding pockets.
Awino JK; Zhao Y
Chemistry; 2015 Jan; 21(2):655-61. PubMed ID: 25382073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
